LXFRMEDIUM SIGNALFINANCIAL10-K

LXFR experienced substantially reduced profitability alongside higher interest costs and weaker cash generation during fiscal 2026.

The company's net income declined meaningfully while interest expense increased substantially, suggesting either higher debt costs or increased borrowing needs that pressured profitability. The weakened operating cash flow generation combined with reduced capital investment may indicate either operational challenges or a more conservative approach to growth spending.

Comparing 2026-02-24 vs 2025-02-25View on EDGAR →
FINANCIAL ANALYSIS

LXFR's financial performance deteriorated notably in fiscal 2026, with net income substantially lower and interest expense meaningfully higher, while operating income declined modestly. Operating cash flow weakened significantly and capital expenditures were reduced, though the company maintained modest share buyback activity. The balance sheet showed improvement with lower total debt and liabilities, while inventory levels increased moderately, presenting a mixed financial picture of operational challenges offset by debt reduction efforts.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+61.5%
$3.9M→$6.3M

Interest expense surged 61.5% — significant debt increase or rising rates materially impacting earnings.

Net Income
P&L
-58.2%
$18.4M→$7.7M

Net income declined 58.2% — review whether driven by operations, interest costs, or non-recurring items.

Share Buybacks
Cash Flow
+34.8%
$2.3M→$3.1M

Share repurchases increased 34.8% — management returning capital, signals confidence in intrinsic value.

Operating Cash Flow
Cash Flow
-33.5%
$51.1M→$34.0M

Operating cash flow fell 33.5% — earnings quality concerns; investigate working capital changes and non-cash items.

Capital Expenditure
Cash Flow
-24.3%
$10.3M→$7.8M

Capex reduced 24.3% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Operating Income
P&L
-20.3%
$30.1M→$24.0M

Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.

Total Debt
Balance Sheet
-12.6%
$45.1M→$39.4M

Debt reduced 12.6% — deleveraging strengthens balance sheet and reduces financial risk.

Total Liabilities
Balance Sheet
-12%
$162.9M→$143.3M

Liabilities reduced 12% — deleveraging improves balance sheet strength and financial flexibility.

Inventory
Balance Sheet
+10.5%
$83.6M→$92.4M

Inventory built 10.5% — monitor whether demand supports this build or if write-downs may follow.

LANGUAGE CHANGES
NEW — 2026-02-24
PRIOR — 2025-02-25
ADDED
Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 7A.
Business Background and business overview Luxfer Holdings PLC ( Luxfer, the Company, we, our ) is a global industrial company focused on niche applications in advanced materials engineering.
We develop and manufacture high-performance materials, components, and high-pressure gas containment solutions for customers operating in defense, first response and healthcare, transportation, and specialty industrial markets.
Luxfer s strategy is centered on value creation through the application of deep technical expertise, proprietary technologies, and close collaboration with customers to solve complex engineering challenges.
Our core product lines include magnesium alloys and powders, zirconium-based chemicals, aluminum and composite high-pressure gas cylinders, and carbon composite technologies.
We believe we hold leading positions in several of our principal markets, including magnesium alloys and powders for aerospace, defense, and commercial applications; zirconium chemicals used in automotive catalytic converters and industrial catalysis; and high-pressure composite cylinders used in self-contained breathing apparatus and in the transport and storage of compressed natural gas ( CNG ) and hydrogen.
Our competitive position is supported by proprietary manufacturing processes, long-standing customer relationships, strong customer service capabilities, and a global manufacturing footprint.
Luxfer operates a global manufacturing network, and operated in 13 facilities during 2025 located in the United States, the United Kingdom, Canada, and China, and maintains a joint venture in Japan.
One manufacturing facility relates to a discontinued operation and one facility ceased operations during 2025.
We employ approximately 1,400 people worldwide, including temporary staff, with fewer than 50 employees supporting discontinued operations.
REMOVED
Management's Discussion and Analysis of Financial Condition and Results of Operations 28 Item 7A.
Business Background and business overview Luxfer Holdings PLC ("Luxfer," "the Company," "we," "our") is a global industrial company innovating niche applications in materials engineering.
Luxfer's high-performance materials, components and high-pressure gas containment devices are used in defense, first response and healthcare, transportation and general industrial applications.
We focus primarily on product lines related to magnesium alloys, zirconium chemicals, aluminum cylinders and carbon composites.
We have a long history of innovation derived from our strong technical expertise, and we work closely with customers to apply solutions to their most demanding product needs.
Our proprietary technologies and technical expertise, coupled with strong customer service and global presence, provide competitive advantages and have established us as leaders in the global markets we serve.
We believe that we have leading positions in key product areas, including magnesium alloys and powders for aerospace, military, and commercial applications, zirconium chemicals for automotive catalytic converters and industrial catalysis, high-pressure composite cylinders for self-contained breathing apparatus, as well as transport and storage of compressed natural gas ("CNG") and hydrogen, photo-engraving plates, and a wide variety of other uses.
We have a global presence, operating 13 manufacturing plants in the U.S., the U.K., Canada and China, one of which relates to discontinued operations, and we also have a joint venture in Japan.
We employ approximately 1,500 people, including temporary staff, of which fewer than 50 support our discontinued operations.
In 2024, our net sales from continuing operations were $391.9 million (2023: $405.0 million, 2022: $423.4 million), and our net income from continuing operations was $18.3 million (2023: $2.6 million loss, 2022: $32.0 income).
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →